Rural expansion of medication treatment for opioid use disorder (CTN-0102). August 1, 2024 to march 31, 2026. N01DA-22-2253. Task order no. 75N95024F00008 (TO24).
Ended Awarded Last action
- Contract number
- 75N95024F00008
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $771,451
Award facts
- Opportunity
-
- 75N95024F00008 Solicitation number
- Contract value 100% obligated
- $771,451.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $771,451 |
About this award
The National Institutes of Health awarded a $771,451 delivery order (Task Order No. 75N95024F00008) to The Emmes Company, LLC on August 1, 2024, under the NIDA Data, Statistics, and Clinical Trial Support Center indefinite delivery vehicle. This task order supports the Rural Expansion of Medication Treatment for Opioid Use Disorder (CTN-0102) initiative, a clinical trials network program administered by the National Institute on Drug Abuse (NIDA). The contract extends through March 31, 2026, with a final completion date of May 31, 2026, and utilizes a cost-plus-fixed-fee pricing structure. The place of performance is Rockville, Maryland, and no small business set-aside was used for this award.
The Emmes Company is a Rockville-based clinical research organization specializing in biostatistical analysis, data management, clinical trial coordination, and regulatory support for federal research initiatives. Under the parent NIDA contract valued at $31.2 million, Emmes provides comprehensive data coordinating center services and clinical trial support across NIDA's research portfolio. This specific task order contributes to expanding medication-assisted treatment options for opioid use disorder in rural areas, aligning with NIDA's priorities in substance abuse treatment research and the agency's broader efforts to address the opioid crisis through evidence-based clinical interventions.
Quick answers
Who was awarded contract 75N95024F00008?
75N95024F00008 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2024.
How much is contract 75N95024F00008 worth?
The government has obligated $771,451 on 75N95024F00008.
Which agency awarded contract 75N95024F00008?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00008, with funding from National Institutes of Health (Department of Health and Human Services).
Is contract 75N95024F00008 an order under another contract?
Yes. 75N95024F00008 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95024F00008 competed?
The extent of competition for 75N95024F00008 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award